Medical Devices

With 26 successful procedures, ForSight Robotics proves its JASPER platform can master cataract surgery, paving the way for AI in the operating room.

More than a new logo, Trimedx's evolution highlights a critical shift where data, AI, and cybersecurity are becoming the lifeblood of hospital operations.

Delcath Systems posts strong revenue and profits, but the real story is its massive investment in expanding its unique liver therapy to fight breast cancer and more.

A stunning quarter for Establishment Labs shows a company moving from high-growth potential to high-growth reality, underpinned by strategic discipline.

Meduloc's $4M Series B, led by GenHenn Capital and backed by Andre Ethier, fuels the launch of its innovative nitinol implant for better fracture healing.

Sotera Health posted stellar Q2 results and raised its 2026 outlook, but a closer look at the numbers reveals a company navigating complex EO litigation.

Cross-Border Impact Ventures secures a $58M first close for its second fund, targeting the vastly underserved but rapidly growing women's and children's health market.

KORU Medical posts record profits, but the real story is its strategic overhaul. We dissect its oncology pivot and digital tech bet for long-term value.

Vienna's P&F acquires AVVie, gaining a novel heart valve technology. This isn't just M&A; it's a high-stakes bid to treat millions left behind.

Lifeward's pilot program with Ottobock Care isn't just a deal; it’s a strategic blueprint for scaling advanced medical tech in a new era of reimbursement.

ZAP Surgical's expansion in China is more than a business win. It signals a future where brain surgery is non-invasive, vault-free, and radically accessible.

LeMaitre reports double-digit growth driven by its Artegraft product, but misses analyst estimates. A deep dive into its global strategy and financial health.

Alphatec's stellar financials are just the surface. We go inside the OR to see how its integrated procedural approach is winning surgeons and changing outcomes.

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

Xtant Medical's leadership heads to a top investor conference, aiming to validate its orthobiologics strategy and prove its path from prototype to profit.

With a strategic investment from UMass Memorial Health, Wellinks is scaling its predictive tech to prevent crises before they start. A new model for chronic care.

Denver Life Sciences won two Red Dot awards for its app, but the real story is how strategic design and deep tech are shaping a new era of personalized health.

A $125k donation reveals a powerful new model for philanthropy, where corporate might and celebrity platforms accelerate life-changing tech for veterans.

GE HealthCare's new LOGIQ e ultrasound family isn't just a product launch; it's a strategic play to dominate point-of-care diagnostics with tiered AI-powered systems.

Saint Agatha Foundation's record grant, born from personal loss, is bringing advanced diagnostic and surgical technology to rural New York, tackling a critical gap.